ZYN, the popular brand of flavored nicotine pouches, recently earned FDA authorization for reducing smoking, but some ...

On January 17, the FDA authorized ZYNs for sale, claiming their benefit to tobacco users outweighed their risk to the public.

Following an extensive scientific review, the US Food and Drug Administration has authorized the marketing of 20 ZYN nicotine pouch products.

The recent decision by the U.S. Food and Drug Administration (FDA) to authorize the marketing of 20 ZYN nicotine pouch ...

In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches.

Zyn products will be allowed to stay on the market after federal health officials Thursday said the popular nicotine pouches can help adult smokers cut back or switch completely. The Food ...

The company did not admit wrongdoing in the settlement. Zyn, an alternative to traditional chewing tobacco products, is a nicotine pouch that does not contain tobacco. Nicotine in adolescence can ...

The U.S. Food and Drug Administration formally authorized Zyn nicotine pouches for sale after conducting an "extensive ...

The FDA determined that due to substantially lower amounts of harmful constituents than cigarettes and most smokeless tobacco products, the authorized nicotine pouches pose a lower risk for cancer ...

"In this instance, the data demonstrate that these nicotine pouch products meet this standard by offering benefits to adults who switch completely from cigarettes and/or smokeless tobacco products ...

After reviewing the scientific evidence, the agency has decided 20 ZYN nicotine pouch products can legally be sold in the US.